Reddit Posts
Do y’all think the Autonomix (NASDAQ: AMIX) IPO tomorrow has the potential to be the TOP IPO of 2024?
EBYH - "We are thrilled to conclude 2023 with our most substantial orders to date".
If an acquisition is announced at $X/share, why would anyone sell it for LESS?!
Individual stocks vs ETF vs REIT vs Robo-investing
BNOX - Bionomics Shares In Rally Mode As Investors Take Interest Ahead Of Planned Phase III Trial To Treat PTSD And SAD ($BNOX)
$NRXS IBS treatment with less side effects than their competitors
Is having a money manager/"Private CFO" worth it?
What would you buy for a short-term medium risk profit expectation right now? Would you sell your most disappointing stock to buy that?
How do I decide between initating a new position vs adding to an existing one?
Looking for help on when to initiate a new position vs DCA an existing one?
Time to dump tech and buy dividend stocks?
Pharmaceuticals break COVID lows trend line signaling end to Bear Market
AbbVie down 7%. Humira sales down 25% As Biosimilars Hammer Away At Sales
AbbVie gains as Skyrizi succeeds in ulcerative colitis (NYSE:ABBV)
2023-02-27 Wrinkle-brain Plays (Mathematically derived options plays)
AbbVie sued in Netherlands for breaching human rights over Humira pricing (NYSE:ABBV)
Next big wave of patent cliffs ahead; expect biopharma M&A to rise (NYSE:ABBV)
$BIOR rising on short squeeze lists. Currently only $30M market cap... Imagine would it could be worth to ABBV as a way to regain patent protection on Humira... explains current $65 price target. Could run incredibly high...
The investor who bought 2.1 Million shares the last session is $7,035,000.00 wealthier in just 24 hours
My short, intermediate, &long and good divident stock reversal confirmed. Shortsqueeze and gamma squeeze (score 87) is a real possibility
AbbVie sets outlook below consensus amid generic threat to best selling drug (NYSE:ABBV)
AbbVie pins hopes on newer drugs and deals to face Humira knockoffs (NYSE:ABBV)
Drug price inflation continues upward momentum at 3.8% – report (NYSE:ABBV)
U.K. pharma lobby urges govt. to halt plans to raise revenue recovery rates (NYSE:ABBV)
AbbVie’s global bestseller Humira to face knockoffs this week (NYSE:ABBV)
My 2022 strategy been working well I guess ¯\_(ツ)_/¯
What are some good healthcare stocks to hold long-term?
Shorting ABBV: Machine Learning Model.
Looking for some constructive advice on my Roth portfolio. What would you cut to get this down to an even 10 stocks?
Why are people throwing money at TEVA after the recent Supreme Court ruling?
Birth control-related pharma plays $OGN $ABBV $TEVA $JNJ
Birth Control-related Pharma Plays $OGN $ABBV $TEVA $JNJ
What did you bought today? Just got some BMO and JPM pretty cheap myself!
$ABBV which trades at $140 has a stake in $XCUR which trades at 18 cents - they are partnered and its all confirmed in partners earnings call. I’ve been going through everything trying to figure out why this is so low and can’t rationalize it. Has .69 cash per share as well.
$XCUR - go through Ipsens Feb 2022 presentation - the partnership with $IPSEY is legit this was at $2 when it was announced. $ABBV must be legit as well:
$XCUR - go through Ipsens Feb 2022 presentation - the partnership with $IPSEY is legit this was at $2 when it was announced. $ABBV must be legit as well:
$XCUR it’s all fucking legit with $ABBV and $IPSEY cant believe it’s at .18 cents. It’s all confirmed on Ipsens earnings call four days ago.
Some big news on $XCUR in most recent $IPSEY Earnings Call they stated the partnerships are continuing. Which means $ABBV partnership still intact. This could be the $BNGO of this year running pennies to dollars.
If you only had to hold a few individual stocks, which would you choose? Or just throw everything in ETFs?
Fat bids on $XCUR all afternoon don’t think this is done. Maybe the partnership with $ABBV and $IPSEY are legit. They just have a shit CEO rn
Big picture on $XCUR is average cost is .80 and PTs range from .40-$6 I just think these prices won’t ever come back. Going long for better or worse but $ABBV partnership isn’t something that can be ignored the Chairman is the CEO of $HZNP
$XCUR - risky play but high risk high reward! The latest filing states the partnerships with ABBV and IPSEY are going fully ahead:
When Partnership news hits $XCUR it’s going straight to $1 at minimum. There’s no way these prices stay this low. When $ABBV announced it ran to $3.30 this could be the next $BNGO pennies to dollars imo
When Partnership news hits $XCUR it’s going straight to $1 at minimum. There’s no way these prices stay this low. When $ABBV announced it ran to $3.30
Partnership news is what will send $XCUR up im holding from .16 waiting til news hits. The partnerships with $ABBV and $IPSEY took it from .90-$3.30 we should have neuroscience partnership news soon worth $1.9B
Partnership news is what will send $XCUR up im holding from .16 waiting til news hits. The partnerships with $ABBV and $IPSEY took it from .90-$3.30 we should have neuroscience partnership news soon worth $1.9B
The major pharma partnerships with $ABBV and $IPSEY make $XCUR extremely undervalued. I can’t wrap head around it under $1 in all honesty. Sorry if keep posting and it’s turned spammy - go through all the DD and make mind up. In my mind it doesn’t make sense when partners were announced it was $3.50
$XCUR - I think it can get to $15 on successful execution of partnerships they have locked contracts with $ABBV (trades $140 and $IPSEY trades $24) worth 4 BILLION in revenue and are in the process of partnering Neuroscience and Pain side in early 2022. Institutions loaded at .33 off last offering:
$XCUR - I think it can get to $15 on successful execution of partnerships they have locked contracts with $ABBV (trades $140 and $IPSEY trades $24) worth 4 BILLION in revenue and are in the process of partnering Neuroscience and Pain side in early 2022. Institutions loaded at .33 off last offering:
$XCUR - I think it can get to $15 on successful execution of partnerships they have locked contracts with $ABBV (trades $140 and $IPSEY trades. $15) worth 4 BILLION in revenue and are in the process of partnering Neuroscience and Pain side in early 2022. Institutions loaded at .33 off last offering:
$XCUR it’s partners trades at $140!!! $ABBV and $IPSEY. The CEO of $HZNP which trades at $90 is chairman of $XCUR - i think this is the next $BNGO and could potentially run to $10 - these partnerships aren’t a joke.
There’s a shit ton of naked shorts in $XCUR is nobody seeing this PA this could really go like $BNGO from pennies to $10+ these are some insane partnerships with major major pharma $ABBV trades at $140
$XCUR is a $PROG 2.0 - some warrants were issued at .01 but they haven’t redeemed the .27 warrants or the shares at .33 per Jan 2022 filing which would push the price to .50 minimum on execution. The neuroscience and pain partner will be announced in 2022 - it did a 60% move on IPSEN and $ABBV news:
$XCUR (currently 16 cents) - $ABBV and $IPSEY 1B Partnership Breakdown:
When $XCUR first IPO’d they issued it a $9 PT the fact it’s 16 cents now is unbelievable with an $ABBV and $IPSEY partnership. If you’re able to buy 100k shares rn and sit for a year or two it’s an easy 5-10X money imo.
$XCUR - Partnered with $ABBV and $IPSEY - is this the next $BNGO type runner 🧐
$XCUR - Partnered with $ABBV and $IPSEY - is this the next $BNGO type runner 🧐
$XCUR - Partnered with $ABBV and $IPSEY - is this the next $BNGO type runner 🧐
$XCUR is very interesting down here partnered with $ABBV
How many of you use leverage or borrowed money to boost your portfolios?
Stocks you can’t wait to see dip because you’re itching to buy them
ABBV Valuation from $111 to $172...just like that huh?
ABBV Valuation from $111 to $172...just like that huh?
Buyout Coming Soon ABBV. Buy all you can, once in a Lifetime here
Earnings for this week & Next week (Me, ABBV, AMC, APPL, etc….)
Stock picks for a 10 year hold with the hope of 5x my money...which ones?
$ABBV short term calls Gain with more to come after Friday announcement with RGNX! Here we go!!!
Let's try $ABBV short term calls. Retina meeting this Friday. Data hopefully is good 10/8 high risk high reward calls. YOLO!
The Cutting Edge: $ATNF, $ABBV, and Adalimumab
Mentions
Timed my ABBV entry horribly. Need this to be the bottom.
Thinking about entering an ABBV swing today. 4/19 1otm calls
ABBV has been solid for me so far, don't know why that'd change Everyone I know has an ALLY account. I had a great experience with them as a car loan servicer. I think they are way under valued if they continue to pick up market share. I think INTC is undervalued. They may have taken a market share hit to AMD but the USG has gone out of their way to be favorable to them because they need to maintain a domestic supply chain for chips as much as they can.
SPY has to gain 3% until April 5th to hit your strike price of 537. SPY has never been that high, we would have to see extremely bullish days for it to hit that 537. What’s going to happen is time will eat away all your money on this call, even if SPY goes up a little the next week you will lose, same thing for the following week. Sorry to be pessimist but it’s unlikely you’re winning this. So for your ABBV position, it’s not as bad. The underlying asset is at 177.50. Your strike price of 180 is kinda close to this but if you’re profitable right now I would sell first thing in the morning tomorrow unless you like risk and want to cross your fingers and hope for green days. Your SLS is ITM but it currently sits at 276% Implied Volatily. Personnaly I wouldn’t have touched that, it’s risky, especially since it dropped 50% last week… Hope for a spike up but it doesn’t look like it’s going your way. AMD put with strike price of 110. Never. AI is what everybody talks about and AMD has its foot in it. For it to go near 110$, a news release as big as « the CEO kidnaps thousand of kids and make them work as slave. » If something along those lines goes out public, then you would have a slight chance of profit.
So my SPY and ABBV are not good ones either? Lol damnit
ABBV has always treated me well, same with JNJ
None of them are really safe. When the tides turn so will I. EPD & ABBV have been in my portfolio the longest.
The only pharma besides LLY and NVO is ABBV
I think index funds are a great way to deploy capital when you don't see any great deals. Since its a market of stocks you can take advantage of buying great companies at a discount when the opportunity arrives when you own individual stocks. I bought ABBV in the 60's in 2019. Everyone thought the company was going out of business, but its fundamentals said otherwise. You can't do that with an index fund, but they are made to dollar cost average into while you look for great deals.
Interesting as I would also pick MSFT and META, not sure what ABBV is I will read up on it. What are your thoughts on NASDAQ 100 vs sp500?
Which do you think is the better buy right now, CVX, LMT or ABBV? sold all my NVDA last week and want to find something new, Im 100% cash right now
Actually that's a good point you brought up as well I never looked at it from that perspective so thanks for the insight my friend!. I will definitely look into that company thank you. In my longterm portfolio my favorite dividend companies are MO and ABBV. MO I just added more last week at $39.
ABBV RSI is 97. ![img](emote|t5_2th52|12787)
Didn't we just go through something similar with ABBV & Humira, which is banging on all time highs now?
PE of around 50. LLY, who also has a weight loss drug, is at 133. Other big Pharma, but without a weigh loss drug, are PFE 72.91, ABBV 66.28, and MRK 876. That looks like a screaming deal for a company that has what equates to the next "little blue pill" in-terms of a commercially successful drug. Add in yesterday's news about a new pill based medication exceeding the efficacy of Wegovy/Ozempic in phase 1 trials and this stock looks like it has so much room to run.
Yeah right. You missed ABBV tho. Botox maker
Hey stranger! Long time! I’m still deep in ABBV… always reminds me of you for some reason.
For the most part none pay crazy high dividends. My largest holdings is Avgo Blackstone JPM Texas Roadhouse ABBV Merck Lvhm Parker Hannifin As examples. I have 58 positions I have small positions in BST and Jepq
USO; K; HE; CELH; FTNT; MRO; WM; ICLN; ABBV; CROX They are using sonic attacks on me. Google "Havanah Syndrome"
JNJ and ABBV are my biggest holdings
I agree. I was going to guy 2 year LEAPS calls on AAPL, SMH, ABBV, and QQQM.
My biggest winners so far have been those unrightfully punished by the market due to one thing or the other - $ABBV, expiring patent, $DIS, political controversy, $BAC, 2023 banking fiasco, $RTX, powder metal issue with engines, $MDT, miracle pill drugs overreaction to medical procedures. Sometimes you just need a quick scan as to what is punished and think logically if it is a short term overreaction. And yes I too have a ton of $RKLB
I like ABBV, ENB, ARCC the best from the list. The depreciating stock price in tobacco should be used with a 25% trailing stop to protect yourself. SBUX is my least favorite here. PFE should have a trailing stop. WPC doesn’t excite me either. Some stocks I like CUBE, CSWC for honorable mention. This portfolio tells a story yet it doesn’t tell the whole story. It looks pretty good.
u/modsaregayasfukkk hope you are well old friend. Was reviewing my ABBV position and thought of you. We bought in sept 2021 if you recall… I swing traded for a bit but starting accumulating Dec 2021. It’s up over 60% since then… spy is up 10%. Should have just bought and held with my whole account. 😂 Be safe buddy
I already own enough ABBV ![img](emote|t5_2th52|4260)
Sold both of them a few months ago, AND kept ABBV and MRK, here are latest 2023 Q4 earnings call summary for both stocks: PFE: [https://www.earningsdigest.ai/stock/analyze/PFE-2023-Q4](https://www.earningsdigest.ai/stock/analyze/PFE-2023-Q4) BMY: [https://www.earningsdigest.ai/stock/analyze/BMY-2023-Q4](https://www.earningsdigest.ai/stock/analyze/BMY-2023-Q4)
PM has been steady/in a range and dividend good. ABBV has been good
Ok. I’m going to help yall out again. It’s $6/share higher since I told yall a week ago. Super low float SMID Cap pharmaceutical. $TARS They offer the only Blepharitis therapeutic on the market, massive first mover advantage. Working on getting into Asia where there’s a massive need. Whole exec team is prior high-powered Allergan execs. Word is: product hit market last August, they haven’t had to report scripts on it yet, they will in March…it’s getting prescribed like gangbusters. Also, chatter about ABBV buyout. https://preview.redd.it/u7k1zlojzoec1.jpeg?width=1290&format=pjpg&auto=webp&s=f714f8084cf1a9190bbd50b81b0bf1fe9e88dc42
How long until there is a big pharma acronym or nickname like big tech does with Mag 7? Seems like there are a bunch of great companies in sector like LLY, NVO, and ABBV. If you throw in insurance UNH.
For dividend growers, I like COST, MCD, AVGO, AMT, ABBV
45M/married/2 kids Full beginner that wants badly to start an individual brokerage account but have some debt I’m trying to pay off first. Do have a company 401k with about $213k but not currently contributing due to the debt. Once that’s cleared, would the below portfolio be satisfactory over time? Obviously I would build up to this. Current prices are scaring me a bit. JPM ABBV PEP KHC XOM HD VOO JNJ PG KO
I would buy credible dividend paying stocks such as O,DIA,KO,MCD,JEPI,ABBV,SPY, & MSFT and just let the dividends payoff the margin and allow your available margin funds to grow by dividend reinvestments. Obviously you would pay a percentage in interest for using margin, but the dividends reinvested pays that off and in time you account grows more in value. Infinite money glitch. *Not financial advice* DD your way through
This has been known for ever and ABBV faced the same. They just bough Seagen and have 44Billion in cash lol
Listen kid I invested in ABBV during 2018. The humira scandal the price sank to 63/68. After purchasing I saw my position go from green to red two years later March of 2020. I didn’t sell or lose my mind. When you have conviction in a stock after it drops you’re happy to buy more at a lower price. Don’t try to predict a recession you can’t. Buy when the price looks good to you and hold its that simple.
ABBV the only thing I have that’s green
Really? I was down .19% but my portfolio is made up mostly of shit that will likely rage this year. ABBV MRK amgn LMT noc all had great days today
Bought in at 190, average of 230. My overly simplistic thesis is paying off now. CF drugs moat is until at least 2037, they’re profitable with decent buyback, competitors have been unsuccessful penetrating CF market (ABBV). The company has 2037 minus current year (2023) of years to diversify their income streams. Basically betting that in a decade and a half, they’ll come out with new drugs and no one would be able to take market share from them in the CF space.
Can't do just 3 but AAPL was the only one I carried through Covid to now. As interest rates are coming down this retiree is looking to add dividend stocks PFE 5.7%, BMY4.8%, SCCO 5.6%, COP 4.17%, SPG 5.77%, F 5.61%, ABBV 4.24%, and another growth stock AMAT. I've made money on all these in the past. I'll balance the rest of my equity allocation in VOO. Probably good for the next 10 years.
Check this out. Someone keeps trading biotech news before they are announced. Last week I showed that a trader made $500k into $3.5 million in 24 hours before $ABBV announced acquiring $IMGN. Someone then traded 56% OTM $EYPT calls, making a million from 100k in a day. This week, someone made thousands trading $CERE before it was bought by $ABBV. I will find them all.
ABBV is on a buying spree. I suspect their purchase of IMGN's platform is driving this new direction.
These are the various individual stocks I have purchased after looking into them. The only ones that in my opinion were more guessing than bluechip were AbbVie, Plains All American, and Greif as I was unfamiliar with them. IRM GEF AAPL COST MSFT PAA KLG ABBV HLT CSCO
ABBV bought it for $31.26 a share, stock is about two bucks less than that. You can either wait for the deal to go through - your shares go away and you get paid the agreed upon price - or you sell and move on. If you wait, there is always the risk that the deal does not go through and then the price will lose a substantial amount/all of the buyout premium (which was very significant in this case.) There is also the possibility of another bidder, but I dunno with the premium that ABBV paid if anyone else is coming along.
I own ABBV and buy it every month - I like the acquisition
I hold some ABBV too. It looks like the market liked the deal, since their stock is up a few percent after announcing.
Maybe not the best, but you can find normalized balance sheets, income statements, and cashflow statements at: [dolthub.com/repositories/post-no-preference/earnings](https://dolthub.com/repositories/post-no-preference/earnings) With dolt, you have access to SQL, so to get AAPL annual balance sheet assets, your query is: select * from balance_sheet_assets where act_symbol = 'AAPL' and period = 'Year'; Similarly, to compare recent income statements between drug makers, you can do: select * from income_statement where act_symbol in ('LLY', 'JNJ', 'ABBV', 'PFE', 'MRK', 'AMGN', 'BMY', 'GILD') and period = 'Quarter' and period_end_date = '2023-06-30'; The repository also includes analyst estimates and an earnings calendar.
So many options. PFE is in same boat as JNJ, ABBV, BMY. These are out of favor currently. Not currently a great future pipeline. Earnings growth slowing. Margins compression. LLY is rocking on weight loss diabetes drug. Wait for Medicare approval. I own all of them. Holding for now due to dividend payout. Still lots of free cash flow. If the Justice Department and FTC were more acquisition friendly........but if those aforementioned companies can't develop and can't buy. Then what?
I would stay away from both VZ and AT&T. Look for a high paying big pharma stock like ABBV
JNJ has the talcum lawsuit. PFE covid hype has died off. ABBV leaving the money in your core position is a higher return and less risk.
Start buying NXGL on the ABBV deal and earnings on Monday!
NXGL. Earning out on Monday and deal with ABBV! float under 5M shares should rocket to 10.00!
NXGL. Earnings Monday and news! Low float under 5M shares with a great catalyst! $AAPL $NXGL earnings Monday! NexGel announced a supply agreement with AbbVie (ABBV - NR) to supply hydrogel pads to be used with AbbVie’s RESONIC Rapid Acoustic Pulse device for improving the appearance of cellulite. AbbVie plans to re-launch RESONIC in 2Q24 and we believe the RESONIC launch can materially accelerate revenues. The agreement further validates NexGel’s leading hydrogel technology as a best- in-class product as this deal follows a recent supply agreement with Haleon (HLN - NR). Large biopharmaceutical companies like AbbVie – with a $250B market cap and Haleon – with a $36B market. We adjust our model to incorporate the RESONIC launch and contributions from the existing and growing business. The additional revenue also leads us to increase our 12-month price target to $6, from $5.
Pharma and biotech are so beaten down right now, but both can benefit from advances in AI technology and remain fields where a big breakthrough can create a seismic shift in profitability. It’s also one of the most difficult places to tell the frauds from the geniuses, unless you have a good background in the sector. Of the big names I like PFE, MRNA, LLY and ABBV, but the winner is likely a small cap I don’t know about.
I have a stock "blow up" every day. Names like WPC, O, ABBV and JPM. Today's dog is OHI, down 6%.
I looked at CVS probably about 5 years ago, ended up going with ABBV. CVS is pretty near what it was 5 years ago, *though they did get a nice run up in that time*. I'm up almost 80% on ABBV in that same time.
You did not say how old you are or when you want to buy the house, which is important info. An inheritance is not money to "gamble". I would recommend putting half into 1-2-3 yr CDs trying to get close to 5% annual return. I would take the other half (&75K?) and put into blue chip qualified dividend paying stocks (ABBV, WMB, O, VALE, MO...) and just take dividends as cash and put into more 1 yr. CD's and generate cash towards a down-payment. In other words, take the $150K and let that make you money. I got an inheritance and I now have $2K/mo in dividends that I use for my monthly house payment, and I don't touch/lower that nest egg, just use it to generate those monthly funds.
This was a good (opportunistic) week. Increased positions in GOOGL, BAC, TSLA, MCD, TMO, ABBV, and IONQ. Opened positions in WHR, CRSP, and TRMB. Enphase can go screw itself. It's a heavy bag I'll be holding for the next 5-10 years to see what happens.
FB, bought at $19 in a taxable account, holding it until I die. ABBV and MRK are two others I will keep.
Lots of hype with this stock, plus, their P/S ratio is more than double JNJ, ABBV, and MRK.
yes, several. i call it my core holdings. they pay dividends. i take the money not lost from the shorts and add it to the core. pick 10 to 25 stocks. every so often if it's at 1 year or more and it's made 10% gain or better sell it, start another core.keep or invest the difference. ABBV is one of my favorites to do this with. I bought 100 shares at 113, sold at 183 2 years later, earlier this year. recently it dropped below 130, it's been more than 32 days, so i picked up 100 shares. this after selling PEP after holding it for 3 years. not all of them are up, but what they are down they make up in dividends, plus if they are down, buy more as long as the company isn't sinking. CLX is another one i play with and its down now. but hay, i'm not a professional at this. i took a 180k inheritance and turned it into 250+- depeding on the day, in 3 years. I only recently started short selling and its not all that. got to be careful with taxes and wash sales. professionals are ginna beat me up now...lol..
ABBV will probably own the space, or some other blue chip like BUD/TAP/MO. No way they letting some small market cap junkies own the space.
I have created my own portfolio of great stocks that include what I call “Market Leaders” in each sector ti be diversified portfolio Health - Hum, Zts, ABBV Technology- MSFT, Nvda, Transportation- Unp Utilities- NEE Consumer Staples- PEP Consumer discretionary - ORLy There are many on other sectors such as Materials, Financials, etc. Then I look at the big players and Funds from Fidelity, Vanguard and others and look at their sector ETFs for the sectors and usually I have investments in the top 5 to 10 stocks that are the same - that tells me that I am right on track.
If I buy a REIT, I probably hold $5k's worth. Drug stocks usually closer to $25k although I have $40K in PFE and ABBV. AAPL, MSFT, NVDA $50k. Most bank stocks $10-15k although I have $57k in NYCB. I usually start a position by using my divvies to start buying it.
Storage REITs, Industrial REITs, Cell tower REITs (e.g. AMT, CCI, etc.), FAANG, Tesla, not sold my BTC (I was once paid 500 BTC back when it broke the $1.00 USD price), Pharma (e.g. - ABT, ABBV, etc.),
Put $64 in ABBV and forget it is there for 2 years. Come back and it will be $180 before the end of 2025
A lot depends on the stock. If it's not a "high quality" company I'll set a range of 25-50% and patiently watch and determine if I should readjust. I took this approach with PTON in at $45 out at 105. With a quality company like XOM that was badly beaten down with its sector, it was a matter of watching it until it reached the average of analyst's forcasts or until it share price leveled off. XOM went on at $45 out at 107. Took a similar approach with ABBV; in at $58 out $142. MRK in at $75 and holding This scenario is a quality company that is a leader in its sector and continues to innovate, dominate and grow. MSFT in at 30 and holding. Same with a leveraged Tech ETF, QLD adjusted (4 splits) purchase $3 and holding. Exit strategy for losers is pretty simple. if it drops 20-25% I'm usually out. Took a 20% hit totaling $6k and put the money to work elsewhere. Final
It's all IRA. 🙂 As a value buyer, I've had a few good ones, but not this good (XOM, PTON ABBV, and a few losers AT&T, Palantier, GE.
Yes just BUY AND HOLD EVERY MONTH 1. buy VOO S and P 500 in 1 account 2.also invest in ABBV for high dividend yield 3.9% 3. A tax tree savings account I usually put in 400$ for Voo 150$ for Abbv 150$ for tax free savings account Over the span of 30 years 1.400$ a month Voo will give you $849,000 2. 150$for ABBV will give you an ending Balance of $758000 and annual income of 216,000$ a year every year. Yes every year even 10,000$ a month is more then enough tbh lol 3.150$ tax free just invest in VOO Do this over the span over 30 years and you’ll have a monster portfolio, you’ll have your S and P 500 which will generate you an insane average of 10% a year, then you have your ABBV which will generate you passive income if you continue to put in around 150$ a month, then you have your tax free savings account if you wanna put a down payment for a home in the future, id also use VOO S and P for that tax free savings account. Just invest at your own pace doesn’t have to be this high could be 200/100/50 how ever you like Understanding compound interest is the 8th wonder of the world This portfolio is the key to building generational wealth , and also you need to re-invest your dividend yields for greater returns for atleast 20 years in my opinion. Take my advice do your own research and you will be ahead of any trader by a mile shot
Suppose you ran a screen, of the 44 biggest companies in the US (>200 bn) and filtered out any that are more than 15% above their 52 week low. https://finviz.com/screener.ashx?v=171&f=cap_mega&ft=3&o=low52w You would get 9 companies. In order, from cheapest: **PFE**, BAC, **JNJ**, **UNH**, PEP, KO, **ABBV**, CVX, **TMO** my conclusion: if you like ETFs with blue chips, buy a healthcare ETF, or a dividend ETF if nothing else, at least they're relatively cheap
Suppose you ran a screen, of the 44 biggest companies in the US (>200 bn) and filtered out any that are more than 15% above their 52 week low. https://finviz.com/screener.ashx?v=171&f=cap_mega&ft=3&o=low52w You would get 9 companies. In order, from cheapest: **PFE**, BAC, **JNJ**, **UNH**, PEP, KO, **ABBV**, CVX, **TMO** my conclusion: if you like ETFs with blue chips, buy a healthcare ETF, or a dividend ETF if nothing else, at least they're relatively cheap
Suppose you ran a screen, of the 44 biggest companies in the US (>200 bn) and filtered out any that are more than 15% above their 52 week low. https://finviz.com/screener.ashx?v=171&f=cap_mega&ft=3&o=low52w You would get 9 companies. In order, from cheapest: **PFE**, BAC, **JNJ**, **UNH**, PEP, KO, **ABBV**, CVX, **TMO** my conclusion: if you like ETFs with blue chips, buy a healthcare ETF, or a dividend ETF if nothing else, at least they're relatively cheap
Suppose you ran a screen, of the 44 biggest companies in the US (>200 bn) and filtered out any that are more than 15% above their 52 week low. https://finviz.com/screener.ashx?v=171&f=cap_mega&ft=3&o=low52w You would get 9 companies. In order, from cheapest: **PFE**, BAC, **JNJ**, **UNH**, PEP, KO, **ABBV**, CVX, **TMO** my conclusion: if you like ETFs with blue chips, buy a healthcare ETF, or a dividend ETF if nothing else, at least they're relatively cheap
I feel like I'm reading myself on my 30's. I had some winners, then got greedy. I bought on margin and actually did well. And then I didn't. And then came the Dot.com bust. And then came losses and a bankruptcy. Oh, and then came the margin call against 'MSFT'. It sucked! I grew up quickly. I sold all the crap in my portfolio, came up with an investing plan (like a business plan) and the past 22 yrs have been stress free investing. I still buy individual stocks, but it's companies like MSFT, MRK, GOOG, ABBV on a long term basis (years!) and funds. Sell the crap. Assume it's not coming back, purge it from your memory and don't look back. You're losses at a young age are an investment in your future wealth. PS Every stock and every ETF is "speculative". IMO, your risk is reduced if you buy into quality companies with a successful business track record and good long term history of profitability and growth.
​ 41% on the dividends, capital gain is only taxed once when you sell (at a flat 26% rate) The performance and quality of american companies are worth the higher tax rate. Many European investors buy american companies for this reason. In my country we don't have companies like ABBV that appreciate 40% in 2 years and pay 5%+ dividends, or a business like microsoft. Also the amount and quality of the analisys on american companies makes it easier to make a decision compared to local companies. I could stick to ETFs to avoid the doube taxation, and that's what I intend to do. Sometimes I just like to buy
At least ABBV got that divi, Kinda like it all though!
10k challenge I’d put 2k in DIS 2k in IBM 2k in QCOM 2k in ABBV and 2k in QQQ
i personally wouldn't be buying general index funds right now unless you plan on holding for 10+ years. all i've been doing lately is tracking down laggards of 2023's bull run. the one's i've found that have been doing well have been CRWD, ABBV, SBUX and HUM. i bought them at a local bottom and plan on holding them until at least 2024.
Cry about ABBV after hours destroying the calls I bought during the dip today and was reeeeaaaallly happy about at close. Probably panic sell and move into another losing move
ABBV comes to mind. Management is constantly looking innovating.
ABBV??? Seems super over sold. Even with good earnings. Thinking about it
Relatively muted response from ABBV with the double beat and guide up. Non Humira drug revenue up. Fortunately i opened my position near the 1 year low about a month ago
ABBV call 144 @ 1.72
Loaded 0dte spy puts TSLA/ABBV 8/4 PUTS
ABBV puts earnings tomorrow morning